Scolaris Content Display Scolaris Content Display

Restricting oral fluid and food intake during labour

Collapse all Expand all

Abstract

Background

Restricting fluids and foods during labour is common practice across many birth settings with some women only being allowed sips of water or ice chips. Restriction of oral intake may be unpleasant for some women, and may adversely influence their experience of labour.

Objectives

To determine the benefits and harms of oral fluid or food restriction during labour.

Search methods

We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 June 2013) and reference lists of retrieved studies.

Selection criteria

Randomised controlled trials (RCTs) and quasi‐RCTs of restricting fluids and food for women in labour compared with women free to eat and drink.

Data collection and analysis

Two review authors independently assessed the studies for inclusion, assessed risk of bias and carried out data extraction.

Main results

We identified 19 studies of which we included five, involving 3130 women. We excluded eight studies, one awaits classification and five are ongoing studies. All the included studies looked at women in active labour and at low risk of potentially requiring a general anaesthetic. One study looked at complete restriction versus giving women the freedom to eat and drink at will; two studies looked at water only versus giving women specific fluids and foods and two studies looked at water only versus giving women carbohydrate drinks.

When comparing any restriction of fluids and food versus women given some nutrition in labour, the meta‐analysis was dominated by one study undertaken in a highly medicalised environment. There were no statistically significant differences identified in: caesarean section (average risk ratio (RR) 0.89, 95% confidence interval (CI) 0.63 to 1.25, five studies, 3103 women), operative vaginal births (average RR 0.98, 95% CI 0.88 to 1.10, five studies, 3103 women) and Apgar scores less than seven at five minutes (average RR 1.43, 95% CI 0.77 to 2.68, four studies, 2902 infants), nor in any of the other outcomes assessed. Women's views were not assessed. The pooled data were insufficient to assess the incidence of Mendelson's syndrome, an extremely rare outcome. Other comparisons showed similar findings, except one study did report a significant increase in caesarean sections for women taking carbohydrate drinks in labour compared with water only, but these results should be interpreted with caution as the sample size was small.

Authors' conclusions

Since the evidence shows no benefits or harms, there is no justification for the restriction of fluids and food in labour for women at low risk of complications. No studies looked specifically at women at increased risk of complications, hence there is no evidence to support restrictions in this group of women. Conflicting evidence on carbohydrate solutions means further studies are needed and it is critical in any future studies to assess women's views.

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.

Plain language summary

Eating and drinking in labour

In some cultures, food and drinks are consumed during labour for nourishment and comfort to help meet the demands of labour. However, in many birth settings, oral intake is restricted in response to work by Mendelson in the 1940s. Mendelson reported that during general anaesthesia, there was an increased risk of the stomach contents entering the lungs. The acid nature of the stomach liquid and the presence of food particles were particularly dangerous, and potentially could lead to severe lung disease or death. Since the 1940s, obstetrical anaesthesia has changed considerably, with better general anaesthetic techniques and a greater use of regional anaesthesia. These advances, and the reports by women that they found the restrictions unpleasant, have led to research looking at these restrictions. In addition, poor nutritional balance may be associated with longer and more painful labours, and fasting does not guarantee an empty stomach or less acidity. This review looked at any restriction of fluids and food in labour compared with women able to eat and drink. The review identified five studies involving 3130 women. Most studies had looked at specific foods being recommended, though one study let women choose what they wished to eat and drink. The review identified no benefits or harms of restricting foods and fluids during labour in women at low risk of needing anaesthesia. There were no studies identified on women at increased risk of needing anaesthesia. None of the studies looked at women's views of restricting fluids and foods during labour. Thus, given these findings, women should be free to eat and drink in labour, or not, as they wish.

Authors' conclusions

Implications for practice

The evidence identified no benefits or harms associated with restricting women's access to fluids and foods during labour for women at low risk of potentially requiring a general anaesthetic, although the studies did not assess women's views or feelings of control. Hence, women should have the autonomy and freedom to choose whether to eat or drink in labour, or not. Women should be able to consume what they desire and in doing so experience no adverse impact on labour, maternal or fetal outcomes. Most women seem to naturally reduce their intake as labour progresses and becomes more intense. We found no evidence from randomised trials on which to base practice regarding food or fluids in labour for women at increased risk of complications.

Implications for research

Further research would be helpful to determine the impact of differing fluids and foods taken during labour, such as carbohydrate solutions. While Mendelson's syndrome is an important adverse outcome, it is very rare and not the most appropriate outcome measure for studies exploring the effectiveness of food and fluid intake during labour. A better approach to the problem of this very rare but important complication of regurgitation during general anaesthesia and Mendelson's syndrome, would be to study interventions that have been shown to be effective at reducing the acidity and volume of stomach contents for elective caesarean section (Paranjothy 2010) to see if such interventions are effective if implemented during labour once it has been decided that a general anaesthetic is required. In addition, research is needed to determine the most effective nutrient and hydration strategies for women in labour within the context of common medical and obstetrical practices, such as epidurals and oxytocin stimulation.

Background

Historically, in some societies, special food and drinks were offered during labour and specific foods were sometimes discouraged (Broach 1988a; McCormick 2002). In the early 1900s, Dr DeLee, an American obstetrician, recommended that women take liquids to preserve their strength during labour (Broach 1988a). However, by the 1940s views had changed, and practitioners believed that eating and drinking in labour might be dangerous. Work by Mendelson in the 1940s showed high morbidity and mortality in women under general anaesthesia for caesarean section who inhaled liquids and particles of food from the stomach (Mendelson 1946). This led to common policies of food and fluid restrictions during labour (Champion 2002). Although many women may not feel like eating in labour (McNabb 2002), some women find this restriction unpleasant and sometimes harrowing (Armstrong 2000; Johnson 1989). The importance of this aspect of a woman's autonomy, choice and control in labour should also be a consideration (Pengelley 2002).

A survey of labour ward policies in England in 1985 revealed that over a third of consultant maternity units allowed no fluids whatsoever during labour (Garcia 1985). In the United States, a survey in 1988 showed that almost half the hospitals and birth centres had a policy of 'nil by mouth' except ice chips (McKay 1988). A later survey of 351 units in England and Wales found that one‐third allowed some form of food and drink and more than 90% allowed some form of oral intake, usually water (Michael 1991). More recently, in 2003, a survey in the UK showed a liberalising trend, with 47% of women having 'access' to food and drink in labour (Hart 2006).   

Description of the condition

Fluid and nutrient needs during labour are not well studied (Micklewright 2002). The need for energy is increased during pregnancy and labour, and metabolic processes generally adjust to address these needs (Pipkin 2001). Many believe that elevated levels of ketone bodies, which accumulate during exercise or starvation (Williamson 1971), and at times during labour are a physiological response with little clinical significance. However, associations between ketone levels and longer labours and maternal psychological stress have been reported (Chang 1993; Foulkes 1985). It is difficult to determine whether ketone production contributes to the longer labour or whether such production is a consequence of longer labour. The presence of ketonuria should be considered a signal for metabolic imbalance, though the effect of the imbalance is not known (Johnson 1989).

Description of the intervention

People take for granted the ability to eat and drink in response to hunger and thirst. Hence, withholding all food and fluids, or withholding all food but allowing only sips of water, from women during labour is an 'intervention'. This intervention is generally used during active labour when women are in hospital, and many women in early labour will eat and drink at will at home. Some hospitals prescribe specific foods which are 'allowed' in labour, but this is also considered an intervention since it limits a women's autonomy and freedom of choice. 

How the intervention might work

The rationale for withholding food and fluid during labour is to decrease the risk of maternal morbidity and mortality from Mendelson's syndrome if a general anaesthetic is required (Mendelson 1946). It was thought that fasting would ensure small gastric volumes, but recent reviews suggest that there is no evidence to support this belief (Micklewright 2002; O'Sullivan 1994). Interventions to reduce stomach contents or the acidity of the content, both by pharmacological means and by restriction of oral intake, have not proved successful (Gyte 2006; Taylor 1975). Also gastric emptying is delayed during labour, which may contribute to the problem (Davidson 1975). Irrespective of whether a woman has been starved or not during labour, anaesthetic precautions are necessary to reduce the risk of gastric content aspiration. These include using regional rather than general anaesthesia, and using rapid sequence induction with airway protection for general anaesthesia (Am Soc Anesth 1999). With modern techniques, particularly the use of regional analgesia, the risk of gastric content aspiration has become extremely small (McKay 1988).

Intravenous therapy instead of oral hydration is common practice during labour. Historically, practitioners administered high‐dose glucose solutions to combat the development of ketones (Ketteringham 1939). More commonly now, intravenous fluids are isotonic or low‐dose glucose, as high‐dose glucose solutions are associated with increased incidence of neonatal hypoglycaemia (low blood sugar levels) (Grylack 1984; Mendiola 1982). Dextrose‐only solutions cause a fall in serum osmolality and sodium concentration (hyponatraemia) (Begum 1999). Regardless of solution type, intravenous therapy predisposes women to immobilisation, stress, increased risk of fluid overload, and does not ensure a nutrient and fluid balance for the demands of labour (Simkin 1986a; Simkin 1986b). The value and safety of routine intravenous fluid therapy has been questioned (Begum 1999).

Why it is important to do this review

Restricting oral food and fluid intake of women in active labour in hospitals is a strongly held obstetric and anaesthetic tradition. Restriction of oral intake is not a common practice in home births or birth centres (Rooks 1989), nor is the practice consistent across hospital sites (Haire 1991). Few, if any, centres have policies that are reflective of women's preferences (Pengelley 1998). Most are based on historical, but important concerns, related to the risks of gastric content regurgitation and aspiration into the lungs during general anaesthesia, a risk first identified by Mendelson in the 1940s. The incidence is very rare with modern anaesthetic techniques and the use of regional anaesthesia rather then general anaesthesia. However, the syndrome is potentially fatal.

The risks of regurgitation and Mendelson's syndrome exist, although the incidence of each is very rare. The policy of routine restriction of foods and fluids in labour in many hospitals across the world generally does not reflect women's preferences or cultural expectations (Broach 1988a; Broach 1988b). It is critical that any policy should be based on evidence of overall benefit to women and babies. This systematic review may assist in resolving the clinical uncertainty, which is currently apparent.

Objectives

To determine the benefits and harms of oral fluid and food restriction during labour, with or without intravenous hydration.

Methods

Criteria for considering studies for this review

Types of studies

We included randomised controlled clinical trials (RCTs). Quasi‐RCTs were eligible for inclusion, however we did not identify any. Had we identified quasi‐RCTs, we would have undertaken sensitivity analysis by study quality.

Types of participants

Women in labour.

Types of interventions

We considered studies comparing any two or more of the following regimens for inclusion. 

  1. Complete restriction of oral food and fluids (other than ice chips).

  2. Allowing only water.

  3. Allowing only oral carbohydrate‐based fluids.

  4. Allowing particular oral food and fluid regimens.

  5. Freedom to take oral food and/or fluids at will.

We then assessed each restrictive regimen (interventions one to four above). In each case, we regarded the more restrictive regimen as the experimental intervention.

We excluded studies on intravenous feeding in labour unless being given on a clinical need within a study on oral fluids and food.

Types of outcome measures

We divided outcomes into maternal and fetal categories. For relative outcomes (e.g. ketoacidosis, dehydration, hyponatraemia, hypoglycaemia, maternal satisfaction, etc), we used the definitions chosen by the trial authors to categorise outcomes.

Primary outcomes
Maternal

  1. Caesarean section.

  2. Operative vaginal birth.

  3. Maternal satisfaction.

Fetal

  1. Five‐minute Apgar score less than seven.

  2. Hypoglycaemia.

Secondary outcomes
Maternal

  1. Ketoacidosis.

  2. Dehydration.

  3. Hyponatraemia.

  4. Hypoglycaemia.

  5. Duration of labour.

  6. Mobility in labour.

  7. Nausea and vomiting.

  8. Labour augmentation.

  9. Narcotic pain relief.

  10. Epidural analgesia.

  11. Poor expulsive efforts.

  12. Regurgitation during general anaesthesia.

  13. Mendelson's syndrome.

  14. Maternal mortality.

  15. Postpartum haemorrhage.

  16. Admission to intensive care.

  17. Length of hospital stay; maternal comfort.

  18. Feelings of pain, thirst, hunger.

  19. Breastfeeding success.

  20. Personal control.

Fetal

  1. Fetal distress.

  2. Cord blood pH less than 7.2.

  3. Hyperinsulinisim.

  4. Hyponatraemia.

  5. Intravenous therapy.

  6. Gavage feeding.

  7. Admission to intensive care.

  8. Length of hospital stay.

We are aware that RCTs are unlikely to be able to adequately address rare adverse outcomes, such as Mendelson's syndrome and maternal mortality in this review, and so we have chosen outcomes which we think might be impacted on, for benefit or harm, by restriction of fluids and foods in labour.

Search methods for identification of studies

Electronic searches

We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting the Trials Search Co‐ordinator (30 June 2013). 

The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: 

  1. monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);

  2. weekly searches of MEDLINE;

  3. weekly searches of Embase;

  4. handsearches of 30 journals and the proceedings of major conferences;

  5. weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.

Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the Cochrane Pregnancy and Childbirth Group

Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords.  

Searching other resources

We searched the reference list for each study identified for any additional studies.

We did not apply any language restrictions.

Data collection and analysis

For the methods used when assessing the trials identified in the previous version of this review, seeAppendix 1.

For this update we used the following methods when assessing the reports identified by the updated search.

Selection of studies

Three review authors (Mandisa Singata (MS), Joan Tranmer (JT) and Gill Gyte (GG)) independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved queries and any disagreement through discussion and we also consulted Therese Dowswell (TD).

Data extraction and management

We designed a form to extract data. For eligible studies, two review authors (either MS, JT, GG with help from LD and TD) extracted the data using the agreed form. We resolved discrepancies through discussion or, when required, we consulted a third person. We entered data (GG) into Review Manager software (RevMan 2011) and checked for accuracy (MS and JT).

When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details.

Assessment of risk of bias in included studies

Two review authors (out of MS, JT and GG, assisted by LD and TD) independently assessed risk of bias for each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We resolved any disagreement by discussion or by involving a third assessor.

(1) Random sequence generation (checking for possible selection bias)

We describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.

We assessed the method as:

  • low risk of bias (any truly random process, e.g. random number table; computer random number generator);

  • high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number);

  • unclear risk of bias.   

(2) Allocation concealment (checking for possible selection bias)

We describe for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.

We assessed the methods as:

  • low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);

  • high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth);

  • unclear risk of bias.   

(3.1) Blinding of participants and personnel (checking for possible performance bias)

We describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.

We assessed the methods as:

  • low, high or unclear risk of bias for participants;

  • low, high or unclear risk of bias for personnel.

(3.2) Blinding of outcome assessment (checking for possible detection bias)

We describe for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received.  We assessed blinding separately for different outcomes or classes of outcomes.

We assessed methods used to blind outcome assessment as:

  • low, high or unclear risk of bias.

(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)

We describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re‐included missing data in the analyses which we undertook.

We assessed methods as:

  • low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);

  • high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation);

  • unclear risk of bias.

(5) Selective reporting (checking for reporting bias)

We describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found.

We assessed the methods as:

  • low risk of bias (where it was clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported);

  • high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so could not be used; study fails to include results of a key outcome that would have been expected to have been reported);

  • unclear risk of bias.

(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)

We describe for each included study any important concerns we have about other possible sources of bias.

We assessed whether each study was free of other problems that could put it at risk of bias:

  • low risk of other bias;

  • high risk of other bias;

  • unclear whether there is risk of other bias.

(7) Overall risk of bias

We make explicit judgements about whether studies were at high risk of bias, according to the criteria given in the Cochrane Handbook (Higgins 2011). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We would have explored the impact of the level of bias through undertaking sensitivity analyses ‐ seeSensitivity analysis ‐ had there been sufficient data. 

Measures of treatment effect

Dichotomous data

For dichotomous data, we present results as summary risk ratio with 95% confidence intervals. 

Continuous data

For continuous data, we used the mean difference if outcomes were measured in the same way between trials. We planned to use the standardised mean difference to combine trials that measure the same outcome, but use different methods.  

Unit of analysis issues

Cluster‐randomised trials

Had we identified any cluster‐randomised trials, we would have included them in the analyses along with individually‐randomised trials. We would have adjusted their sample sizes using the methods described in the Cochrane Handbook Section 16.3.4 using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If, in future updates, we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely.

We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit.

Cross‐over trials

We believe that cross‐over designs will be invalid for this topic and so have excluded them.

Other unit of analysis issues

To date, we have not identified studies that involve multiple pregnancies. If we identify such studies in the future, we will use special methods to analyse these data (see the Pregnancy and Childbirth Group Methodological Guidelines and Cochrane Handbook sections 9.3.7 and 16.3).

To date, we have not identified studies with more than two treatment groups. If we identify such studies in the future we will use special methods to analyse outcome data ‐ see Cochrane Handbook section 16.4.7.

Dealing with missing data

For included studies, we noted levels of attrition. Had it been required, we would have explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.

For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes are known to be missing.

Assessment of heterogeneity

We assessed statistical heterogeneity in each meta‐analysis using the T², I² and Chi² statistics. We regarded heterogeneity as substantial if the I² was greater than 30% and either the T² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. 

Assessment of reporting biases

If there had been 10 or more studies in the meta‐analysis, we would have investigated reporting biases (such as publication bias) using funnel plots. We would have assessed funnel plot asymmetry using formal tests for funnel plot asymmetry. For continuous outcomes we would have used the test proposed by Egger 1997, and for dichotomous outcomes we would have used the test proposed by Harbord 2006. If asymmetry had been detected in any of these tests, we would have performed exploratory analyses to investigate it.

Data synthesis

We carried out statistical analysis using the Review Manager software (RevMan 2011). We used fixed‐effect meta‐analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials’ populations and methods are judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average range of possible treatment effects and we discuss the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials.

If we used random‐effects analyses, the results are presented as the average treatment effect with 95% confidence intervals, and the estimates of  T² and I².

Subgroup analysis and investigation of heterogeneity

If we had identified substantial heterogeneity, we planned to investigate it using subgroup analyses and sensitivity analyses. We would consider whether an overall summary is meaningful, and if it is, use random‐effects analysis to produce it.

We planned to carry out the following subgroup analyses.

  1. Women at low risk of potentially requiring general anaesthesia versus women at high risk of potentially requiring general anaesthesia. We looked at all outcomes for this subgroup analysis as we believed this to be such an important consideration.

  2. Routine administration of intravenous (IV) fluids in the restricted group versus no routine administration of IV fluids in the restricted group. We restricted these analyses to primary outcomes only.

We were unable to undertake the subgroup analysis comparing the administration of IV fluids as the data did not exist.

We assessed differences between subgroups by interaction tests.

Sensitivity analysis

We carried out sensitivity analysis to explore the effect of trial quality for primary outcomes in the review. Where there was risk of bias associated with a particular aspect of study quality (e.g. inadequate allocation concealment), we have explored this by sensitivity analysis.

Results

Description of studies

Results of the search

The search identified 30 publications covering 19 studies. Of these, we have included five studies involving 3130 women in this review (Kubli 2002; O'Sullivan 2009; Scheepers 2002; Scrutton 1999; Tranmer 2005), excluded eight studies (Ciura 2012; Goodall 1999; Kardel 2010; Laifer 2000; Scheepers 2004; Shennan 2005; Yiannouzis 1994; Zhao 1996); one study is awaiting classification (Kordi 2010) and a further five trials are ongoing (Davila‐Exposito 2009; Espinosa 2011; Heidari 2012; Simonet 2012; Yarvani 2011).

Included studies

All of the included studies involved women considered at low risk of potentially requiring general anaesthesia (for example, for caesarean section). No studies looked specifically at women considered at increased risk of general anaesthesia.

Of the five included studies, only one study looked at restricting women to only ice chips or sips of water compared with giving women the freedom to eat and drink what they wished during labour. The women who were able to choose what they ate and drank in labour did have some guidance antenatally with easy‐to‐read guidelines on suggested nutrition and fluid intake during labour based on nutritional guidelines for individuals who participate in prolonged, moderate aerobic exercise (Tranmer 2005). Two included studies looked at restricting women to drinking water only compared with giving women specific foods during labour and encouraging them to take some food and fluids in active labour (O'Sullivan 2009; Scrutton 1999). The remaining two studies looked at giving women water only compared with carbohydrate drinks in labour (Kubli 2002; Scheepers 2002).

Excluded studies

We excluded eight of the 19 studies identified. We excluded one study because it was a discussion paper (Shennan 2005) and another because it looked at giving a high glucose load once women reached 8 cm to 10 cm dilatation (Scheepers 2004). Two studies looked at women given energy drinks in addition to oral food intake and there was no restriction of fluids and food (Ciura 2012; Kardel 2010). One study in Chinese had no data available despite our having the paper translated, and we were also unsure from this paper just what the intervention and comparison groups were (Zhao 1996). For two studies which fitted our inclusion criteria, sadly the data were not available (Goodall 1999; Yiannouzis 1994). See Characteristics of excluded studies.

Risk of bias in included studies

The studies were of reasonable overall quality although some aspects, such as selective reporting bias, were unclear. However, the review is dominated by one large trial of reasonable overall quality involving 2443 women (O'Sullivan 2009), while the other four studies together involve just 687 women (Kubli 2002; Scheepers 2002; Scrutton 1999; Tranmer 2005). For the Methodological quality summary, seeFigure 1.


Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Allocation

Three studies had adequate sequence generation and allocation concealment (O'Sullivan 2009; Scheepers 2002; Tranmer 2005). One study had adequate sequence generation but allocation concealment was unclear (Kubli 2002) and one study was unclear for both adequate sequence generation but allocation concealment (Scrutton 1999).

Blinding

The only study that blinded the women and the clinicians was the study comparing carbohydrate fluids with coloured water (Scheepers 2002). Studies that looked at women in labour eating and drinking compared with women having ice chips or water only were not able to blind women or clinicians, and hence some outcomes may be subject to bias.

Incomplete outcome data

We considered all studies to have complete outcome data reported. There were a few exclusions but these were very small compared with the overall numbers of women involved (seeCharacteristics of included studies).

Selective reporting

The assessment of selective reporting bias was considered adequate for the one study where we were able to assess the trial protocol as reported in the PhD thesis (Tranmer 2005). We assessed the other studies as unclear on selective reporting bias, as we were unable to assess the trial protocols.

Other potential sources of bias

Three studies were assessed as free of other sources of bias (Kubli 2002; Scheepers 2002; Scrutton 1999). For the other studies we assessed this aspect as unclear.

Effects of interventions

1. Any restriction of oral fluid and food versus some eating and drinking (five studies, 3130 women)

Five studies assessed this comparison (Kubli 2002; O'Sullivan 2009; Scheepers 2002; Scrutton 1999; Tranmer 2005). The overall quality of the studies was reasonable with three studies having adequate randomisation sequence generation, allocation concealment and no exclusions of loss to follow‐up (O'Sullivan 2009; Scheepers 2002; Tranmer 2005). The large size of the O'Sullivan 2009 study in comparison with the size of the other studies means that for any outcome that included data from the O'Sullivan 2009 study will be dominated by these data. This study was undertaken in a highly medicalised environment where women entering the study were considered to have no known obstetric or medical complication that would increase the likelihood of an operative birth, yet 30% of women in the trial had a caesarean section. Other interventions, including oxytocin augmentation, IV fluids, epidurals, and instrumental births, also showed high rates in this study (Table 1).

Open in table viewer
Table 1. Interventions during labour in women at low risk in O'Sullivan study

Intervention

Water only

Food in labour

Oxytocin augmentation

56% (673/1207)

53% (647/1219)

IV fluids in labour

69% (838/1207)

67% (820/1219)

Epidural

67% (813/1207)

66% (804/1219)

Caesarean section

30% (363/1207)

30% (362/1219)

Operative vaginal birth

27% (310/1207)

27% (324/1219)

IV: intravenous

Since in this comparison we were pooling a range of restrictive practices and a range on comparison forms of care, we considered we had clinical heterogeneity. We, therefore, used the random‐effects model of meta‐analyses as we did not expect a single common (or 'fixed') effect underlying every study in the meta‐analysis. Rather, we assumed that the individual studies were estimating different treatment effects and that the different effects had a distribution with some central value and some degree of variability. For those analyses where there was moderate or high statistical heterogeneity (I2 greater than 30%), we have provided estimates of Tau2 I2 and the P value of the Chi2 test for heterogeneity.

Primary outcomes

Reporting all the meta‐analyses as random‐effects, we identified no significant differences in:

  • caesarean section (average risk ratio (RR) 0.89, 95% confidence interval (CI) 0.63 to 1.25, five studies, 3103 women, (T2 = 0.07, Chi2 P = 0.05, I2 = 57%), Analysis 1.1);

  • operative vaginal birth (average RR 0.98, 95% CI 0.88 to 1.10, five studies, 3103 women, Analysis 1.2);

  • Apgar scores less than seven at five minutes (average RR 1.43, 95% CI 0.77 to 2.68, four studies, 2902 infants, Analysis 1.4).

None of the studies assessed maternal satisfaction or infant hypoglycaemia.

Secondary outcomes

Reporting all the meta‐analyses as random‐effects, we identified no significant differences in:

  • maternal ketosis (average RR 0.99, 95% CI 0.66 to 1.49, one study, 328 women, Analysis 1.6);

  • duration of labour (average mean difference (MD) ‐0.29, 95% CI ‐1.55 to 0.97, three studies, 476 women, (T2 = 0.72, Chi2 P = 0.09, I2 = 58%), Analysis 1.10);

  • maternal nausea (average RR 0.80, 95% CI 0.54 to 1.18, one study, 255 women, Analysis 1.12);

  • maternal vomiting (average RR 0.90, 95% CI 0.62 to 1.31, three studies, 2574 women, (T2 = 0.06, Chi2 P = 0.13, I2 = 50%), Analysis 1.13);

  • augmentation of labour (average RR 1.02, 95% CI 0.95 to 1.09, five studies, 3103 women, Analysis 1.14);

  • narcotic pain relief (average RR 0.94, 95% CI 0.74 to 1.21, three studies, 349 women, (T2 = 0.04, Chi2 P = 0.0002, I2 = 88%), Analysis 1.15);

  • epidural analgesia (average RR 0.98, 95% CI 0.91 to 1.05, five studies, 3103 women, Analysis 1.16);

  • infant admission to intensive care (average RR 1.03, 95% CI 0.73 to 1.45, one study, 2426 infants, Analysis 1.34).

Regurgitation during anaesthesia and Mendelson's syndrome were not estimable (Analysis 1.18; Analysis 1.19) and other secondary outcomes were not assessed in the included studies.

Although we have chosen to use a random‐effects model throughout this comparison, for some outcomes there appeared to be no statistical heterogeneity (e.g. for Analysis 1.2 Operative vaginal delivery and Analysis 1.4 Apgar score less than seven at five minutes, for both I2 = 0% and Tau2 = 0). 

2. Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink (one study, 330 women)

Only one study looked at complete restrictions to fluid and food (ice chips only or sips of water only) intake compared with women having the freedom to eat and drink at will. Although there were discussions antenatally about suggested nutrient and fluid intake during labour based on nutritional guidelines for individuals who participate in exercise (prolonged, moderate, aerobic), the women were encouraged to bring to the hospital their own food and drink choices and caregivers did not actively encourage or discourage oral intake in the group able to eat and drink (Tranmer 2005).

The quality of the study was good overall, with adequate sequence generation, allocation concealment and no exclusions nor loss of data (seeFigure 1).

Primary outcomes

There were no significant differences identified in:

  • caesarean sections (RR 0.77, 95% CI 0.51 to 1.16, one study, 328 women, Analysis 2.1);

  • operative vaginal births (RR 0.99, 95% CI 0.72 to 1.35, one study, 328 women, Analysis 2.2).

There were no infants with Apgar scores less than seven at five minutes, and the other primary outcomes of maternal satisfaction and neonatal hypoglycaemia were not assessed in the included study.

Secondary outcomes

There were no significant differences identified in:

  • maternal ketosis (RR 0.99, 95% CI 0.66 to 1.49, one study, 328 women, Analysis 2.6);

  • duration of labour (MD ‐0.80, 95% CI ‐2.13 to 0.53, one study, 328 women, Analysis 2.10);

  • maternal nausea (RR 0.80, 95% CI 0.54 to 1.18, one study, 255 women, Analysis 2.12);

  • augmentation of labour (RR 0.98, 95% CI 0.81 to 1.18, one study, 328 women, Analysis 2.14);

  • epidural (RR 0.92, 95% Ci 0.81 to 1.04, one study, 328 women, Analysis 2.16).

Mendelson's syndrome was not estimable, and the other secondary outcomes were not assessed in this one included study.

3. Water only versus freedom to eat and drink (no studies)

There were no studies identified looking at this comparison.

4. Oral carbohydrate based fluids versus freedom to eat and drink (no studies)

There were no studies identified looking at this comparison.

5. Specific oral fluid and food versus freedom to eat and drink (no studies)

There were no studies identified looking at this comparison.

6. Complete restriction of oral fluid and food (other than ice chips versus specific oral foods and fluids (no studies)

There were no studies identified looking at this comparison.

7. Water only versus particular oral fluid and food (two studies, 2520 women)

Two studies looked at the comparison of restricting women to taking only water during active labour compared with advising and encouraging women to take low‐residue foods in labour (O'Sullivan 2009; Scrutton 1999). Neither study was able to blind women or clinicians and this may have impacted on the assessment of some outcomes. The large O'Sullivan 2009 study (2426 women) had adequate randomisation sequence generation, allocation concealment and had no significant exclusions or loss of data. The other small study (94 women) was of unclear quality as there was insufficient information available to assess adequately (Scrutton 1999).

Primary outcomes

There were no significant differences identified in:

  • caesarean section (RR 1.02, 95% CI 0.91 to 1.15, two studies, 2514 women, Analysis 7.1);

  • operative vaginal birth (RR 0.96, 95% CI 0.84 to 1.10, two studies, 2514 women, Analysis 7.2);

  • Apgar scores less than seven at five minutes (RR 1.39, 95% CI 0.73 to 2.63, two studies (although only one was estimable), 2514 infants, Analysis 7.4).

The other primary outcomes of maternal satisfaction and neonatal hypoglycaemia were not assessed in these included studies.

Secondary outcomes

There were no significant differences identified in:

  • duration of labour (MD ‐1.10, 95% CI ‐2.66 to 0.46, one study, 88 women, Analysis 7.10);

  • maternal vomiting (average RR 0.76, 95% CI 0.41 to 1.41, two studies, 2514 women, random‐effects (T2 = 0.15, Chi2 P = 0.08, I2 = 68%), Analysis 7.13);

  • augmentation of labour (average RR 0.97, 95% CI 0.80 to 1.19, two studies, 2514 women, random‐effects (T2 = 0.01, Chi2 P = 0.08, I2 = 67%), Analysis 7.14);

  • narcotic pain relief (RR 1.00, 95% CI 0.91 to 1.09, one study, 88 women, Analysis 7.15);

  • epidural analgesia (RR 1.02, 95% CI 0.97 to 1.08, two studies, 2514 women, Analysis 7.16);

  • infant admission to intensive care (RR 1.03, 95% CI 0.73 to 1.45, one study, 2426 infants, Analysis 7.34).

Regurgitation during anaesthesia and Mendelson's syndrome were not estimable (Analysis 7.18; Analysis 7.19) and other secondary outcomes were not assessed in the included studies.

8. Oral carbohydrate based fluids versus specific oral fluid and food (no studies)

There were no studies identified looking at this comparison.

9. Complete restriction of fluid and food (other than ice chips) versus oral carbohydrate based fluids (no studies)

There were no studies identified looking at this comparison.

10. Water only versus oral carbohydrate based fluids (two studies, 263 women)

Two studies looked at restricting women to water only compared with giving them carbohydrate drinks (Kubli 2002; Scheepers 2002). We assessed the larger study (203 women of mixed risk) to be of good quality with only the selective reporting bias being unclear (Scheepers 2002). We assessed the smaller study (60 women of low risk) as unclear for allocation concealment, blinding and selective reporting boas (Kubli 2002).

Primary outcomes

There were no significant differences identified in:

  • caesarean section (average RR 0.66, 95% CI 0.17 to 2.53, two studies, 261 women, random‐effects (T2 = 0.74, Chi2 P = 0.03, I2 = 79%), Analysis 10.1);

  • operative vaginal birth (RR 1.17, 95% CI 0.80 to 1.71, two studies, 261 women, Analysis 10.2);

  • Apgar scores less than seven at five minutes (RR 3.00, 95% CI 0.13 to 70.83, one study, 60 infants, Analysis 10.4).

The other primary outcomes of maternal satisfaction and neonatal hypoglycaemia were not assessed in these studies.

Secondary outcomes

There were no significant differences identified in:

  • duration of labour (MD 0.95, 95% CI ‐0.42 to 2.32, one study, 60 women, Analysis 10.10);

  • maternal vomiting (RR 1.27, 95% CI 0.69 to 2.33, one study, 60 women, Analysis 10.13);

  • augmentation of labour (RR 1.07, 95% CI 0.75 to 1.52, two studies, 261 women, Analysis 10.14);

  • narcotic pain relief (average RR 0.86, 95% CI 0.36 to 2.06, two studies, 261 women, random‐effects (T2 = 0.38, Chi2 P = 0.00001, I2 = 95%), Analysis 10.15);

  • epidural analgesia (average RR 0.80, 95% CI 0.44 to 1.43, two studies, 261 women, random‐effects (T2 = 0.14, Chi2 P = 0.04, I2 = 76%), Analysis 10.16).

The other secondary outcomes were not assessed in the included studies.

Discussion

Summary of main results

This review includes five studies involving 3130 women. There are four comparisons with associated data and 41 meta‐analyses.

For women considered at low risk of potentially needing general anaesthesia

We identified no benefits or risks of restricting oral fluids and foods in labour, in women at low risk of potentially requiring general anaesthesia in this review. In particular, in none of the primary outcomes of caesarean section, operative vaginal birth and five‐minute Apgar score less than seven did we see any statistically significant difference between the groups. Maternal satisfaction and hypoglycaemia, both also primary outcomes in this review, were not reported in any of the included studies. No women included in this review suffered from regurgitation during general anaesthesia or Mendelson's syndrome, a very rare complication in modern anaesthesia. We were not able to undertake a systematic review of such adverse outcomes, but plan to do so in a future update if data become available. There were no significant differences identified in any of the outcomes assessed in the review for women at low risk of potentially needing general anaesthesia in any of the comparisons made, though this may be related to the small numbers of women involved in the assessment of some individual outcomes. However, one large study dominated the findings in this meta‐analysis (O'Sullivan 2009) and this hospital had high medical intervention rates. In particular, this study (O'Sullivan 2009) included only women with no known obstetric or medical complication that would increase the likelihood of an operative birth, yet 30% of women in the study had a caesarean section. It may be that in less medicalised environments there might be differences in outcomes identified. Also, women were told that "...eating was not recommended in labour...but were actively encouraged to do so if randomised to the feeding arm". Since most women do not want conflict with their caregivers, this may have influenced their behaviour.

Only one study looked at restricting oral intake in labour with women who had freedom to eat and drink at will during labour. No benefits or risks of restricting women in this way were identified for women at low risk of needing a general anaesthetic.

Looking at restricting women to water only compared with giving them carbohydrate drinks during labour, identified different findings for the two studies (Kubli 2002; Scheepers 2002). One study, involving 203 women, showed a reduction in caesarean section for women taking water only (risk ratio (RR) 0.34, 95% confidence interval (CI) 0.15 to 0.77, 201 women) and the authors postulated that this may be due to a re‐distribution of blood flow to the gastrointestinal tract from the myometrium (Scheepers 2002). However, the other study found no difference in the incidence of caesarean sections (RR 1.33, 95% CI 0.53 to 3.38, 60 women). It is unclear where this difference arises from and could merely be a result of small numbers of women included in the studies. It would be important to investigate this further as some carbohydrate drinks may increase the risk of caesarean section. It would be worth comparing the use of carbohydrate drinks compared with freedom to eat and drink at will during labour to see if this really is a problem.

For women at increased risk of potentially needing general anaesthesia

There were no studies looking at this population of women. Again, the better general anaesthetic techniques and the increased use of regional anaesthesia mean that the incidence of Mendelson's syndrome and regurgitation during general anaesthesia are very rare in this population of women as well.

Overall completeness and applicability of evidence

When considering any restriction of fluids and food during labour compared with some fluids and food available to women, the pooled data are dominated by one large study involving 2443 women at low risk of complications (O'Sullivan 2009). However, in this study there were very high intervention rates, particularly for women considered at low risk of complications (over 50% oxytocin augmentation, just under 70% getting intravenous fluids and epidurals in labour, 30% caesarean sections, 27% operative vaginal births). In addition, 20% of the women in the water‐only arm ate during labour and 29% of the women in the food and fluids arm chose not to eat in labour (Table 1). This clearly reflects the wide variation in women's wishes for food and fluids during labour.

Quality of the evidence

The overall quality of the evidence was reasonable (Figure 1).

Potential biases in the review process

The possibility of introducing bias was present at every stage of reviewing process. We attempted to minimise bias in a number of ways; two review authors assessed eligibility for inclusion, carried out data extraction and assessed risk of bias. Each worked independently. Nevertheless, the process of assessing risk of bias, for example, is not an exact science and includes many personal judgements.

Agreements and disagreements with other studies or reviews

Although restricting fluids and foods during labour has been standard policy in many countries over many years (McCormick 2002; Pengelley 1998), current policies are tending to be less restrictive (NICE 2007). This possibly reflects an acknowledgement of the lack of evidence to restrict women's access to fluids and food during labour (NICE 2007) and some women's unpleasant and harrowing experiences of such restrictions (Armstrong 2000; Johnson 1989). Although NICE suggested that women should be informed that isotonic drinks may be more beneficial than water, our evidence suggests otherwise (NICE 2007). Where NICE looked at one study (Kubli 2002) that assessed the impact of isotonic drinks on blood levels of biochemical substances, we assessed the impact on clinical outcomes and included all studies assessing carbohydrate solutions, with one study showing an increase in caesarean sections with carbohydrate solutions compared with water. There clearly needs to be more research on this aspect.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
Figures and Tables -
Figure 1

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 1 Caesarean section (primary outcome).
Figures and Tables -
Analysis 1.1

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 1 Caesarean section (primary outcome).

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 2 Operative vaginal birth (primary outcome).
Figures and Tables -
Analysis 1.2

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 2 Operative vaginal birth (primary outcome).

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 4 Apgar < 7 at 5 min (primary outcome).
Figures and Tables -
Analysis 1.4

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 4 Apgar < 7 at 5 min (primary outcome).

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 6 Maternal ketoacidosis.
Figures and Tables -
Analysis 1.6

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 6 Maternal ketoacidosis.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 10 Duration of labour (hours).
Figures and Tables -
Analysis 1.10

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 10 Duration of labour (hours).

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 12 Maternal nausea.
Figures and Tables -
Analysis 1.12

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 12 Maternal nausea.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 13 Maternal vomiting.
Figures and Tables -
Analysis 1.13

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 13 Maternal vomiting.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 14 Augmentation of labour.
Figures and Tables -
Analysis 1.14

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 14 Augmentation of labour.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 15 Narcotic pain relief.
Figures and Tables -
Analysis 1.15

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 15 Narcotic pain relief.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 16 Epidural analgesia.
Figures and Tables -
Analysis 1.16

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 16 Epidural analgesia.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 18 Regurgitation during general anaesthesia.
Figures and Tables -
Analysis 1.18

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 18 Regurgitation during general anaesthesia.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 19 Mendelson's syndrome.
Figures and Tables -
Analysis 1.19

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 19 Mendelson's syndrome.

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 34 Infant admission to intensive care.
Figures and Tables -
Analysis 1.34

Comparison 1 Any restriction of oral fluid and food versus some fluid and food, Outcome 34 Infant admission to intensive care.

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 1 Caesarean section (primary outcome).
Figures and Tables -
Analysis 2.1

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 1 Caesarean section (primary outcome).

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 2 Operative vaginal birth (primary outcome).
Figures and Tables -
Analysis 2.2

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 2 Operative vaginal birth (primary outcome).

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 4 Apgar < 7 at 5 min (primary outcome).
Figures and Tables -
Analysis 2.4

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 4 Apgar < 7 at 5 min (primary outcome).

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 6 Maternal ketoacidosis.
Figures and Tables -
Analysis 2.6

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 6 Maternal ketoacidosis.

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 10 Duration of labour (hours).
Figures and Tables -
Analysis 2.10

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 10 Duration of labour (hours).

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 12 Maternal nausea.
Figures and Tables -
Analysis 2.12

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 12 Maternal nausea.

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 14 Augmentation of labour.
Figures and Tables -
Analysis 2.14

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 14 Augmentation of labour.

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 16 Epidural analgesia.
Figures and Tables -
Analysis 2.16

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 16 Epidural analgesia.

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 19 Mendelson's syndrome.
Figures and Tables -
Analysis 2.19

Comparison 2 Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink, Outcome 19 Mendelson's syndrome.

Comparison 7 Water only versus specific oral fluid and food, Outcome 1 Caesarean section (primary outcome).
Figures and Tables -
Analysis 7.1

Comparison 7 Water only versus specific oral fluid and food, Outcome 1 Caesarean section (primary outcome).

Comparison 7 Water only versus specific oral fluid and food, Outcome 2 Operative vaginal birth (primary outcome).
Figures and Tables -
Analysis 7.2

Comparison 7 Water only versus specific oral fluid and food, Outcome 2 Operative vaginal birth (primary outcome).

Comparison 7 Water only versus specific oral fluid and food, Outcome 4 Apgar < 7 at 5 min (primary outcome).
Figures and Tables -
Analysis 7.4

Comparison 7 Water only versus specific oral fluid and food, Outcome 4 Apgar < 7 at 5 min (primary outcome).

Comparison 7 Water only versus specific oral fluid and food, Outcome 10 Duration of labour (hours).
Figures and Tables -
Analysis 7.10

Comparison 7 Water only versus specific oral fluid and food, Outcome 10 Duration of labour (hours).

Comparison 7 Water only versus specific oral fluid and food, Outcome 13 Maternal vomiting.
Figures and Tables -
Analysis 7.13

Comparison 7 Water only versus specific oral fluid and food, Outcome 13 Maternal vomiting.

Comparison 7 Water only versus specific oral fluid and food, Outcome 14 Augmentation of labour.
Figures and Tables -
Analysis 7.14

Comparison 7 Water only versus specific oral fluid and food, Outcome 14 Augmentation of labour.

Comparison 7 Water only versus specific oral fluid and food, Outcome 15 Narcotic pain relief.
Figures and Tables -
Analysis 7.15

Comparison 7 Water only versus specific oral fluid and food, Outcome 15 Narcotic pain relief.

Comparison 7 Water only versus specific oral fluid and food, Outcome 16 Epidural analgesia.
Figures and Tables -
Analysis 7.16

Comparison 7 Water only versus specific oral fluid and food, Outcome 16 Epidural analgesia.

Comparison 7 Water only versus specific oral fluid and food, Outcome 18 Regurgitation during general anaesthesia.
Figures and Tables -
Analysis 7.18

Comparison 7 Water only versus specific oral fluid and food, Outcome 18 Regurgitation during general anaesthesia.

Comparison 7 Water only versus specific oral fluid and food, Outcome 19 Mendelson's syndrome.
Figures and Tables -
Analysis 7.19

Comparison 7 Water only versus specific oral fluid and food, Outcome 19 Mendelson's syndrome.

Comparison 7 Water only versus specific oral fluid and food, Outcome 34 Infant admission to intensive care.
Figures and Tables -
Analysis 7.34

Comparison 7 Water only versus specific oral fluid and food, Outcome 34 Infant admission to intensive care.

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 1 Caesarean section (primary outcome).
Figures and Tables -
Analysis 10.1

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 1 Caesarean section (primary outcome).

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 2 Operative vaginal birth (primary outcome).
Figures and Tables -
Analysis 10.2

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 2 Operative vaginal birth (primary outcome).

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 4 Apgar < 7 at 5 min (primary outcome).
Figures and Tables -
Analysis 10.4

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 4 Apgar < 7 at 5 min (primary outcome).

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 10 Duration of labour (hours).
Figures and Tables -
Analysis 10.10

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 10 Duration of labour (hours).

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 13 Maternal vomiting.
Figures and Tables -
Analysis 10.13

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 13 Maternal vomiting.

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 14 Augmentation of labour.
Figures and Tables -
Analysis 10.14

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 14 Augmentation of labour.

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 15 Narcotic pain relief.
Figures and Tables -
Analysis 10.15

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 15 Narcotic pain relief.

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 16 Epidural analgesia.
Figures and Tables -
Analysis 10.16

Comparison 10 Water only versus oral carbohydrate based fluids, Outcome 16 Epidural analgesia.

Table 1. Interventions during labour in women at low risk in O'Sullivan study

Intervention

Water only

Food in labour

Oxytocin augmentation

56% (673/1207)

53% (647/1219)

IV fluids in labour

69% (838/1207)

67% (820/1219)

Epidural

67% (813/1207)

66% (804/1219)

Caesarean section

30% (363/1207)

30% (362/1219)

Operative vaginal birth

27% (310/1207)

27% (324/1219)

IV: intravenous

Figures and Tables -
Table 1. Interventions during labour in women at low risk in O'Sullivan study
Comparison 1. Any restriction of oral fluid and food versus some fluid and food

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Caesarean section (primary outcome) Show forest plot

5

3103

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.63, 1.25]

1.1 Women at low risk of caesarean/complications

5

3103

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.63, 1.25]

1.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2 Operative vaginal birth (primary outcome) Show forest plot

5

3103

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.88, 1.10]

2.1 Women at low risk of caesarean/complications

5

3103

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.88, 1.10]

2.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3 Maternal satisfaction (primary outcome)

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

3.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4 Apgar < 7 at 5 min (primary outcome) Show forest plot

4

2902

Risk Ratio (M‐H, Random, 95% CI)

1.43 [0.77, 2.68]

4.1 Women at low risk of caesarean/complications

4

2902

Risk Ratio (M‐H, Random, 95% CI)

1.43 [0.77, 2.68]

4.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

4.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

5 Neonatal hypogylcaemia (primary outcome)

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

5.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

5.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

5.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

6 Maternal ketoacidosis Show forest plot

1

328

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.66, 1.49]

6.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.66, 1.49]

6.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

6.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

7 Maternal dehydration

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

7.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

7.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

7.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

8 Maternal hyponatraemia

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

8.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

8.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

8.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

9 Maternal hypoglycaemia

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

9.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

9.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

9.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

10 Duration of labour (hours) Show forest plot

3

476

Mean Difference (IV, Random, 95% CI)

‐0.29 [‐1.55, 0.97]

10.1 Women at low risk of caesarean/complications

3

476

Mean Difference (IV, Random, 95% CI)

‐0.29 [‐1.55, 0.97]

10.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

10.3 Women with no defined risk status

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

11 Mobility in labour

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

11.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

11.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

11.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

12 Maternal nausea Show forest plot

1

255

Risk Ratio (M‐H, Random, 95% CI)

0.80 [0.54, 1.18]

12.1 Women at low risk of caesarean/complications

1

255

Risk Ratio (M‐H, Random, 95% CI)

0.80 [0.54, 1.18]

12.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

12.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

13 Maternal vomiting Show forest plot

3

2574

Risk Ratio (M‐H, Random, 95% CI)

0.90 [0.62, 1.31]

13.1 Women at low risk of caesarean/complications

3

2574

Risk Ratio (M‐H, Random, 95% CI)

0.90 [0.62, 1.31]

13.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

13.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

14 Augmentation of labour Show forest plot

5

3103

Risk Ratio (M‐H, Random, 95% CI)

1.02 [0.95, 1.09]

14.1 Women at low risk of caesarean/complications

5

3103

Risk Ratio (M‐H, Random, 95% CI)

1.02 [0.95, 1.09]

14.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

14.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

15 Narcotic pain relief Show forest plot

3

349

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.74, 1.21]

15.1 Women at low risk of caesarean/complications

3

349

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.74, 1.21]

15.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

15.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

16 Epidural analgesia Show forest plot

5

3103

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.91, 1.05]

16.1 Women at low risk of caesarean/complications

5

3103

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.91, 1.05]

16.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

16.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

17 Poor maternal expulsive efforts

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

17.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

17.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

17.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

18 Regurgitation during general anaesthesia Show forest plot

1

2426

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

18.1 Women at low risk of caesarean/complications

1

2426

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

18.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

18.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

19 Mendelson's syndrome Show forest plot

2

2754

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

19.1 Women at low risk of caesarean/complications

2

2754

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

19.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

19.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

20 Maternal mortality

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

20.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

20.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

20.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

21 Postpartum haemorrhage (> 1000 ml)

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

21.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

21.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

21.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

22 Maternal admission to intensive care

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

22.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

22.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

22.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

23 Length of maternal hospital stay

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

23.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

23.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

23.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

24 Maternal comfort

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

24.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

24.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

24.3 Women with no defined risk status

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

25 Maternal feelings of pain, thirst or hunger

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

25.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

25.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

25.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

26 Fully breastfeeding at discharge

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

26.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

26.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

26.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

27 Maternal feelings of control

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

27.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

27.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

27.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

28 Fetal distress

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

28.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

28.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

28.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

29 Cord blood pH < 7.2

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

29.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

29.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

29.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

30 Infant hyperinsulinism

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

30.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

30.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

30.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

31 Infant hyponatraemia

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

31.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

31.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

31.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

32 Infant intravenous therapy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

32.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

32.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

32.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

33 Infant gavage feeding

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

33.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

33.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

33.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

34 Infant admission to intensive care Show forest plot

1

2426

Risk Ratio (M‐H, Random, 95% CI)

1.03 [0.73, 1.45]

34.1 Women at low risk of caesarean/complications

1

2426

Risk Ratio (M‐H, Random, 95% CI)

1.03 [0.73, 1.45]

34.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

34.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

35 Length of infant hospital stay

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

35.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

35.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

35.3 Women with no defined risk status

0

0

Mean Difference (IV, Random, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 1. Any restriction of oral fluid and food versus some fluid and food
Comparison 2. Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Caesarean section (primary outcome) Show forest plot

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.77 [0.51, 1.16]

1.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.77 [0.51, 1.16]

1.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Operative vaginal birth (primary outcome) Show forest plot

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.99 [0.72, 1.35]

2.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.99 [0.72, 1.35]

2.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Maternal satisfaction (primary outcome)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4 Apgar < 7 at 5 min (primary outcome) Show forest plot

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5 Neonatal hypogylcaemia (primary outcome)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6 Maternal ketoacidosis Show forest plot

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.99 [0.66, 1.49]

6.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.99 [0.66, 1.49]

6.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7 Maternal dehydration

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Maternal hypoglycaemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9 Maternal hyponatraemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

10 Duration of labour (hours) Show forest plot

1

328

Mean Difference (IV, Fixed, 95% CI)

‐0.80 [‐2.13, 0.53]

10.1 Women at low risk of caesarean/complications

1

328

Mean Difference (IV, Fixed, 95% CI)

‐0.80 [‐2.13, 0.53]

10.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

10.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

11 Mobility in labour

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12 Maternal nausea Show forest plot

1

255

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.54, 1.18]

12.1 Women at low risk of caesarean/complications

1

255

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.54, 1.18]

12.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13 Maternal vomiting

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14 Augmentation of labour Show forest plot

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.81, 1.18]

14.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.81, 1.18]

14.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15 Narcotic pain relief

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

16 Epidural analgesia Show forest plot

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.81, 1.04]

16.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.81, 1.04]

16.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

16.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17 Poor maternal expulsive efforts

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18 Regurgitation during general anaesthesia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19 Mendelson's syndrome Show forest plot

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.1 Women at low risk of caesarean/complications

1

328

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20 Maternal mortality

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21 Postpartum haemorrhage (> 1000 ml)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22 Maternal admission to intensive care

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23 Length of maternal hospital stay

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

24 Maternal comfort

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

25 Maternal feelings of pain, thirst or hunger

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26 Fully breastfeeding at discharge

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27 Maternal feelings of control

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28 Fetal distress

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29 Cord blood pH < 7.2

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30 Infant hyperinsulinism

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31 Infant hyponatraemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32 Infant intravenous therapy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33 Infant gavage feeding

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34 Infant admission to intensive care

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

35 Length of infant hospital stay

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 2. Complete restriction of oral fluid and food (other than ice chips) versus freedom to eat and drink
Comparison 7. Water only versus specific oral fluid and food

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Caesarean section (primary outcome) Show forest plot

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.91, 1.15]

1.1 Women at low risk of caesarean/complications

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.91, 1.15]

1.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2 Operative vaginal birth (primary outcome) Show forest plot

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.84, 1.10]

2.1 Women at low risk of caesarean/complications

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.84, 1.10]

2.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Maternal satisfaction (primary outcome)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4 Apgar < 7 at 5 min (primary outcome) Show forest plot

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

1.39 [0.73, 2.63]

4.1 Women at low risk of caesarean/complications

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

1.39 [0.73, 2.63]

4.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5 Neonatal hypogylcaemia (primary outcome)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6 Maternal ketoacidosis

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7 Maternal dehydration

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Maternal hyponatraemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9 Maternal hypoglycaemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

10 Duration of labour (hours) Show forest plot

1

88

Mean Difference (IV, Fixed, 95% CI)

‐1.10 [‐2.66, 0.46]

10.1 Women at low risk of caesarean/complications

1

88

Mean Difference (IV, Fixed, 95% CI)

‐1.10 [‐2.66, 0.46]

10.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

10.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

11 Mobility in labour

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12 Maternal nausea

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13 Maternal vomiting Show forest plot

2

2514

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.41, 1.41]

13.1 Women at low risk of caesarean/complications

2

2514

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.41, 1.41]

13.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

13.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

14 Augmentation of labour Show forest plot

2

2514

Risk Ratio (M‐H, Random, 95% CI)

0.97 [0.80, 1.19]

14.1 Women at low risk of caesarean/complications

2

2514

Risk Ratio (M‐H, Random, 95% CI)

0.97 [0.80, 1.19]

14.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

14.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

15 Narcotic pain relief Show forest plot

1

88

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.91, 1.09]

15.1 Women at low risk of caesarean/complications

1

88

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.91, 1.09]

15.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

16 Epidural analgesia Show forest plot

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.97, 1.08]

16.1 Women at low risk of caesarean/complications

2

2514

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.97, 1.08]

16.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

16.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17 Poor maternal expulsive efforts

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18 Regurgitation during general anaesthesia Show forest plot

1

2426

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.1 Women at low risk of caesarean/complications

1

2426

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19 Mendelson's syndrome Show forest plot

1

2426

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.1 Women at low risk of caesarean/complications

1

2426

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20 Maternal mortality

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21 Postpartum haemorrhage (> 1000 ml)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22 Maternal admission to intensive care

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23 Length of maternal hospital stay

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

24 Maternal comfort

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

25 Maternal feelings of pain, thirst or hunger

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26 Fully breastfeeding at discharge

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27 Maternal feelings of control

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28 Fetal distress

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29 Cord blood pH < 7.2

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30 Infant hyperinsulinism

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31 Infant hyponatraemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32 Infant intravenous therapy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33 Infant gavage feeding

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34 Infant admission to intensive care Show forest plot

1

2426

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.73, 1.45]

34.1 Women at low risk of caesarean/complications

1

2426

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.73, 1.45]

34.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

35 Length of infant hospital stay

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 7. Water only versus specific oral fluid and food
Comparison 10. Water only versus oral carbohydrate based fluids

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Caesarean section (primary outcome) Show forest plot

2

261

Risk Ratio (M‐H, Random, 95% CI)

0.66 [0.17, 2.53]

1.1 Women at low risk of caesarean/complications

2

261

Risk Ratio (M‐H, Random, 95% CI)

0.66 [0.17, 2.53]

1.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

1.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2 Operative vaginal birth (primary outcome) Show forest plot

2

261

Risk Ratio (M‐H, Fixed, 95% CI)

1.17 [0.80, 1.71]

2.1 Women at low risk of caesarean/complications

2

261

Risk Ratio (M‐H, Fixed, 95% CI)

1.17 [0.80, 1.71]

2.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3 Maternal satisfaction (primary outcome)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4 Apgar < 7 at 5 min (primary outcome) Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

3.0 [0.13, 70.83]

4.1 Women at low risk of caesarean/complications

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

3.0 [0.13, 70.83]

4.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5 Neonatal hypoglycaemia (primary outcome)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6 Maternal ketoacidosis

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7 Maternal dehydration

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8 Maternal hyponatraemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9 Maternal hypoglycaemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

10 Duration of labour (hours) Show forest plot

1

60

Mean Difference (IV, Fixed, 95% CI)

0.95 [‐0.42, 2.32]

10.1 Women at low risk of caesarean/complications

1

60

Mean Difference (IV, Fixed, 95% CI)

0.95 [‐0.42, 2.32]

10.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

10.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

11 Mobility in labour

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12 Maternal nausea

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13 Maternal vomiting Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

1.27 [0.69, 2.33]

13.1 Women at low risk of caesarean/complications

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

1.27 [0.69, 2.33]

13.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14 Augmentation of labour Show forest plot

2

261

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.75, 1.52]

14.1 Women at low risk of caesarean/complications

2

261

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.75, 1.52]

14.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15 Narcotic pain relief Show forest plot

2

261

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.36, 2.06]

15.1 Women at low risk of caesarean/complications

2

261

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.36, 2.06]

15.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

15.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

16 Epidural analgesia Show forest plot

2

261

Risk Ratio (M‐H, Random, 95% CI)

0.80 [0.44, 1.43]

16.1 Women at low risk of caesarean/complications

2

261

Risk Ratio (M‐H, Random, 95% CI)

0.80 [0.44, 1.43]

16.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

16.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

17 Poor maternal expulsive efforts

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18 Regurgitation during general anaesthesia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19 Mendelson's syndrome

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20 Maternal mortality

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21 Postpartum haemorrhage (> 1000 ml)

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22 Maternal admission to intensive care

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23 Length of maternal hospital stay

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

23.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

24 Maternal comfort

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

25 Maternal feelings of pain, thirst or hunger

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26 Fully breastfeeding at discharge

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27 Maternal feelings of control

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28 Fetal distress

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29 Cord blood pH < 7.2

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30 Infant hyperinsulinism

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31 Infant hyponatraemia

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32 Infant intravenous therapy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

32.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33 Infant gavage feeding

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

33.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34 Infant admission to intensive care

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34.1 Women at low risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34.2 Women at increased risk of caesarean/complications

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

34.3 Women with no defined risk status

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

35 Length of infant hospital stay

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.1 Women at low risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.2 Women at increased risk of caesarean/complications

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

35.3 Women with no defined risk status

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 10. Water only versus oral carbohydrate based fluids